Research Article
Expression of miR-652-3p and Effect on Apoptosis and Drug Sensitivity in Pediatric Acute Lymphoblastic Leukemia
Table 1
Baseline characteristics of healthy children and pediatric patients with ALL (serum samples).
| | No | Sample type | Sex | Age (at ND) | Chromosome | CR duration |
| | 1 | Healthy control | Male | 3 | None | - - | | 2 | Healthy control | Female | 9 | None | - - | | 3 | Healthy control | Female | 12 | None | - - | | 4 | ND and matched CR | Male | 4 | t(12;21) | - - | | 5 | ND and matched CR | Female | 11 | None | - - | | 6 | ND and matched CR | Female | 8 | None | - - | | 7 | RE | Male | 3 | t(12;21) | 23 months | | 8 | RE | Female | 7 | None | 31 months | | 9 | RE | Female | 12 | None | 43 months |
|
|
ALL: acute lymphoblastic leukemia; CR: complete remission; ND: new diagnosis; RE: relapse
|
